Updates on the Evolving Treatment Paradigm in Sickle Cell Disease: A Focus in Managed Care

Updates on the Evolving Treatment Paradigm in Sickle Cell Disease: A Focus in Managed Care

On-Demand 1.0 hour Accredited Webcast

Faculty Presenter

Lametra L. Scott, PharmD
Executive Director
Breaking The Ssickle Cell Cycle Foundation, Inc.
Nashville, Tennessee
 
Program Description
Sickle cell disease (SCD) is an inherited blood disorder with life-threatening complications that can lead to hospitalizations and poor quality of life for patients. Complications of SCD include vaso-occlusive events, which can affect multiple organ systems and increase disease severity, resulting in hospitalizations. Treatment approaches for patients with SCD include pain management, preventive care, and routine health management. As not all patients with SCD tolerate or respond to standard-of-care treatments, newer therapies that address the underlying pathophysiology are promising. Reducing vaso-occlusive events and associated hospitalizations for patients with SCD should be of utmost consideration for managed care professionals when reviewing institutional protocols and facilitating patient access to therapies for SCD. This activity will explore challenges and complexities of managing patients with SCD, as well as present cost-efficacy data for managed care professionals to utilize when seeking to optimize healthcare resource utilization.

Target Audience: Managed care pharmacists
Type of Activity: Application
Release date: July 14, 2021
Expiration date: July 14, 2022
Time to complete activity: 1.0 hour
Fee: Free

Educational Objectives
At the completion of this activity, participants will be able to:

• Explore the pathophysiology of sickle cell disease (SCD), the associated comorbidities, and complications of SCD to help facilitate access to treatment to optimize care.
• Analyze the current treatment standards, existing gaps in care, and emerging therapies to improve management of SCD.
• Investigate the available data on new and emerging treatment strategies in SCD to improve care and optimize healthcare resource utilization.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-21-279-H01-P. The activity is available for CE credit through July 14, 2022.


Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, view the webcast in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
 

---

Disclosures

Lametra L. Scott, PharmD, has the following relevant financial relationships with commercial interests to disclose:
Consultant: ACCEL Grant Review Committee

Pharmacy Times Continuing Education™ Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Meg Taylor, PharmD, CPP; Liz Rauh; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose.

Anonymous peer reviewers are used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms